Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
Pharma companies say AI has cut early discovery timelines by as much as half while Anthropic positions itself as a competitor and partner.
5 Articles
5 Articles
The world's largest pharmaceutical companies are cutting early-stage drug development time by up to half with the help of artificial intelligence. The process from designing new molecules to starting clinical trials has been significantly accelerated, while technology giants such as Anthropic, which is going public this week, are opening their own research laboratories and becoming partners and direct competitors to traditional pharmaceutical pl…
Big Pharma, with eye on Anthropic, says AI is shrinking drug discovery timelines
NEW YORK/LONDON, Nov 20 : Artificial intelligence has sped up early-stage drug development work at some of the world's largest pharmaceutical companies this year, cutting by as much as half the time it takes to produce new molecules and move them into the clinic, according to their top scientists.GSK, Bristol
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








